Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
2.465
-0.085 (-3.33%)
At close: May 15, 2026, 4:00 PM EDT
2.490
+0.025 (1.01%)
After-hours: May 15, 2026, 6:23 PM EDT
Imunon Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
9.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 500.00K | - | - |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | 500.00K | - | - |
| Dec 31, 2019 | 500.00K | - | - |
| Dec 31, 2018 | 500.00K | - | - |
| Dec 31, 2017 | 500.00K | - | - |
| Dec 31, 2016 | 500.00K | - | - |
| Dec 31, 2015 | 500.00K | - | - |
| Dec 31, 2014 | 500.00K | - | - |
| Dec 31, 2013 | 500.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | 2.00M | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | 2.50M | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIMNN News
- 4 days ago - Imunon reports Q1 EPS (84c), consensus ($1.28) - TheFly
- 4 days ago - Imunon Earnings Call Transcript: Q1 2026 - Transcripts
- 4 days ago - IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 11 days ago - IMUNON to Hold First Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, May 12, 2026 - GlobeNewsWire
- 4 weeks ago - Imunon initiated with a Buy at Maxim - TheFly
- 6 weeks ago - Imunon Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study - GlobeNewsWire
- 7 weeks ago - Imunon announces final clinical data from OVATION 2 clinical trial - TheFly